Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin

Pancreatic cancer is the fourth most common cause of cancer mortality worldwide. Furthermore, patients with pancreatic cancer experience limited benefit from current chemotherapeutic approaches because of drug resistance. Therefore, an effective therapeutic strategy for patients with pancreatic canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao Dong, Zhao, Yan, Zhang, Min, He, Rui Zhi, Shi, Xiu Hui, Guo, Xing Jun, Shi, Cheng Jian, Peng, Feng, Wang, Min, Shen, Min, Wang, Xin, Li, Xu, Qin, Ren Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343905/
https://www.ncbi.nlm.nih.gov/pubmed/28208617
http://dx.doi.org/10.3390/ijms18020370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343905/
https://www.ncbi.nlm.nih.gov/pubmed/28208617
http://dx.doi.org/10.3390/ijms18020370

Ejemplares similares